Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00327951 · ClinicalTrials.gov registry record

Infant Weight Gain With Trisomy 21 and CAVC

A clinical trial, sponsored by Children's Healthcare of Atlanta.

Terminated
Registry status
46
Enrollment target

NCT00327951: Clinical Trial study, sponsored by Children's Healthcare of Atlanta.

NCT00327951 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00327951 was terminated before completion, sponsored by Children's Healthcare of Atlanta.

TERMINATED
Registry status
46 participants
Enrollment target

Study Summary

Failure to thrive and difficulty gaining weight is a sign of uncompensated congestive heart failure (CHF). Infants with Trisomy 21 and complete atrioventricular canal defects (CAVC) frequently develop uncompensated CHF and weight gain failure pre-operatively. A weight of 5 kg has been suggested as optimal for timing of CAVC repair. A delay in surgical repair often occurs if weight gain stalls and reaches a plateau prior to reaching 5 kg. A retrospective review performed by Kogon, et al, of children undergoing surgery for VSD at CHOA at Egleston recently reported that age and weight at surgery may not, however, be associated with adverse surgical outcome. The purpose of this study is to determine the optimal timing for surgical correction of CAVC in Trisomy 21 infants based on reaching a plateau of failed weight gain despite maximal anti-congestive and nutritional therapy.

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2001-01
Est. Completion 2008-02
Children's Healthcare of Atlanta

80 total trials

Why NCT00327951 stopped before completion

NCT00327951 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00327951 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00327951 about?

NCT00327951 is a clinical study titled "Infant Weight Gain With Trisomy 21 and CAVC". Failure to thrive and difficulty gaining weight is a sign of uncompensated congestive heart failure (CHF). Infants with Trisomy 21 and complete atrioventricular canal defects (CAVC) frequently develop uncompensated CHF and weight gain failure pre-operatively. A weight of 5 kg has been suggested as o...

What is the current status of trial NCT00327951?

This trial is currently terminated. The enrollment target is 46 participants. The study started on 2001-01. Estimated completion is 2008-02.

Who is sponsoring clinical trial NCT00327951?

This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00327951, the US trial registry maintained by the National Library of Medicine. NCT00327951 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.